Total Content: 5mg of high-stability lyophilized (freeze-dried) powder per vial
[DOI] [PMC free article] [PubMed] [Google Scholar] 164.Voehringer D.W., McConkey D.J., McDonnell T.J., Brisbay S., Meyn R.E
TGIF, transforming growth-interacting factor
KPV Proposed use : wound healing and inflammatory conditions Outcome : Yes Margin : 8-6 in favor, with one abstention What the FDA was saying : The nominator did not provide clinical evidence for that proposed use, and lacked human studies
Other lupus symptoms to note : Although the rash does not leave scarring, it could cause discoloration after it disappears
Ships from US and Canada warehouses in 13 business days